Bicocca Open Archive

Logo unimib boa
ARCANGELI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.203
EU - Europa 2.751
AS - Asia 1.052
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 3
Totale 10.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.145
IT - Italia 691
IE - Irlanda 617
DE - Germania 465
SG - Singapore 410
SE - Svezia 317
CN - Cina 307
RU - Federazione Russa 305
HK - Hong Kong 245
GB - Regno Unito 118
UA - Ucraina 105
FR - Francia 59
CA - Canada 56
VN - Vietnam 38
FI - Finlandia 22
IN - India 20
ID - Indonesia 14
NL - Olanda 12
DK - Danimarca 10
TR - Turchia 9
CZ - Repubblica Ceca 7
AT - Austria 4
GR - Grecia 4
IR - Iran 4
ES - Italia 3
EU - Europa 3
PL - Polonia 3
RO - Romania 3
SA - Arabia Saudita 3
SC - Seychelles 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
MX - Messico 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
LT - Lituania 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PE - Perù 1
TH - Thailandia 1
Totale 10.019
Salva come PNG Salva come JPEG
Città #
Fairfield 1.047
Ann Arbor 823
Dublin 612
Ashburn 453
Frankfurt am Main 430
Woodbridge 429
Wilmington 402
Seattle 394
Singapore 372
Cambridge 341
Houston 341
Santa Clara 332
Hong Kong 245
Princeton 237
New York 183
Milan 148
Chandler 122
Altamura 110
Lawrence 108
Dearborn 89
Jacksonville 87
San Diego 69
Nanjing 67
Rome 45
Andover 41
Beijing 34
Shanghai 32
Toronto 28
Dong Ket 26
Ottawa 26
Hebei 24
Nanchang 22
Shenyang 22
London 21
Helsinki 20
Guangzhou 17
Jiaxing 14
Jakarta 12
Jinan 12
Lissone 12
Fremont 11
Pune 11
Redmond 10
Sulzano 10
Cologna Veneta 9
Munich 9
Norwalk 9
Changsha 8
Palermo 8
Olomouc 7
Zhengzhou 7
Anzio 6
Chicago 6
Los Angeles 6
Naples 6
Tianjin 6
Verona 6
Bari 5
Brescia 5
Cagliari 5
Huizen 5
Kiev 5
Monza 5
San Mateo 5
Athens 4
Berlin 4
Boardman 4
Chiswick 4
Falls Church 4
Fuzhou 4
Genoa 4
Hefei 4
Messina 4
Nave 4
Perugia 4
Amantea 3
Boulder 3
Bucharest 3
Dallas 3
Florence 3
Kocaeli 3
Kunming 3
Leawood 3
Lonigo 3
Madrid 3
Mahé 3
Mountain View 3
Ningbo 3
Pisa 3
Southwark 3
Torino 3
Turin 3
Washington 3
Zanjan 3
Ankara 2
Antony 2
Azzano San Paolo 2
Bernareggio 2
Bollate 2
Carnago 2
Totale 8.132
Salva come PNG Salva come JPEG
Nome #
Effetti immunologici della radioterapia 368
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 258
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 247
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 240
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: A secondary analysis from a randomized study 192
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 179
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 171
Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study 151
Optimal scheduling of hypofractionated radiotherapy for localized prostate cancer: A systematic review and metanalysis of randomized clinical trials 150
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy 144
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 128
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer 125
Phase I-II study of intraoperative radiation therapy (IORT) after radical prostatectomy for prostate cancer 124
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area 116
GUROPA survey: genito-urinary radiation oncology prescription attitudes 116
1539 poster TUMOR CONTROL PROBABILITY IN STEREOTACTIC RADIO-SURGERY FOR BRAIN METASTASES 115
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 113
DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans 112
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 112
Moderate hypofractionation in high-risk, organ-confined prostate cancer: Final results of a phase III randomized trial 111
Epidemiology of prostate cancer and treatment remarks. 110
Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer 110
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer 109
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials 108
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 108
Mathematical Model for Evaluating Incidence of Acute Rectal Toxicity During Conventional or Hypofractionated Radiotherapy Courses for Prostate Cancer 107
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial 106
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 105
Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC 104
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group 104
Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer 103
Moderate hypofractionation for prostate cancer 103
International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study 103
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity 103
Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours 101
Hypofractionated radiotherapy for organ-confined prostate cancer: Is less more? 101
Postoperative Hypofractionated Radiotherapy for Prostate Cancer 100
Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: A further step toward new evidence 100
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer 100
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era 99
Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer 97
Clinical and Dosimetric Predictors of Acute Toxicity After a 4-Week Hypofractionated External Beam Radiotherapy Regimen for Prostate Cancer: Results From a Multicentric Prospective Trial 97
EORTC radiation proctitis-specific quality of life module - pretesting in four European countries 97
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 96
Extreme hypofractionation for early prostate cancer: Biology meets technology 96
Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI 96
Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study 96
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 95
Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy? 94
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC) 94
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease 94
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review. 92
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 92
Updated Results and Pattern of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer 92
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. 92
Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed 90
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO) 89
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery 88
Dose-escalated Radiotherapy for Stage III Unresectable Non-small Cell Lung Cancer: Have We Come to a Standstill? 88
Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture? 87
A Systematic Review of Radical Cystectomy Versus Organ Preserving Trimodal Therapy in Muscle-Invasive Bladder Cancer 87
Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations 87
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. 87
Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysis. 87
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer 86
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. 86
Re-irradiation for esophageal cancer 85
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial 85
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 83
Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control 83
Hypofractionation and Stereotactic Treatment: Clinical Data 82
Review and uses of stereotactic body radiation therapy for oligometastases 81
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: a potential comparison bias 81
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature 80
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 78
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments 78
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review 77
From radiobiology to technology: what is changing in radiotherapy for prostate cancer 76
Vertebral metastases reirradiation with volumetric-modulated arc radiotherapy 74
Is Hypofractionated (Chemo) radiation Delivered With Helical Tomotherapy a Feasible Option to Escalate the Dose in Locally- Advanced Inoperable NSCLC?: Results From a Phase 2 Trial 72
Radiation therapy of breast cancer. Reasoned approach to a clinical case 69
Safety culture to improve accidental event reporting in radiotherapy 69
Underlying anatomy for CTV contouring and lymphatic drainage in rectal cancer radiation therapy 67
Re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 66
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience 65
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 62
External beam radiation therapy in the treatment of the prostate adenocarcinoma in the elderly 61
Stereotactic Body Radiation Therapy With Ablative Dose on Liver Metastases: Radiation-induced Liver Disease (RILD) and Toxicity Assessment 59
Dose and volume as predictive factors of pulmonary toxicity 59
Guidelines on prostate carcinoma - AIRO, 2016 59
Re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy 58
Single fraction partial breast irradiation in prone position 53
The role of palliative radiotherapy in the management of elderly and frail patients with advanced bladder cancer: A survey by the AIRO uro-group 50
A Multicenter Large Retrospective Database on the Personalization of Stereotactic Ablative Radiotherapy for Lung Metastases From Colon-Rectal Cancer: The LaIT-SABR Study 50
Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study 49
Principi di Radioterapia 48
Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking 47
Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 44
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 44
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 41
Totale 9.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.500 0 0 0 0 182 271 294 217 216 106 155 59
2020/20211.701 74 89 187 196 195 137 150 199 105 135 115 119
2021/20221.056 83 133 115 49 27 53 42 178 41 35 88 212
2022/20231.648 275 484 194 75 69 271 30 56 100 15 48 31
2023/20241.498 30 23 34 144 164 358 385 29 169 26 29 107
2024/20251.303 146 581 159 141 276 0 0 0 0 0 0 0
Totale 10.680